Viratech Corp. Announces e-Book on Open Source Biotech Research

Viratech Corp. has rolled out its e-Book, "Open Source (News - Alert) Cancer Research," which discusses ways the open source biotech research social network platform works to make it possible for individuals or smaller companies to participate with larger companies in the race to patent new medicines or technology.

The book has been written by Dr. Kevin Buckman, which can be purchased at Amazon.

Dr. Kevin Buckman is the founder of Viratech, and understands the goals of and opportunities for the company. He developed many of the technologies that are key components of Viratech, and holds a vast resume of medical experience.

Dr. Buckman has experience as CEO and other business roles that compliment his goals to move the company forward.

Buckman has continuous research in this field, having led to his technologies in Non-Harmful Medicine with Early Diagnosis and Treatments, especially in the field of Women’s Health. He has published books including Find and Stop Breast Cancer and Find and Stop Diabetes.

Viratech Corp. takes credit for creating an open source biotech research social network platform that helps individuals or smaller companies to compete with larger companies, and this was done by using social collaboration in a way that allows new biotech ventures the ability to protect their intellectual property, then simultaneously allowing those same ventures to promote and crowdsource their development.

The organization’s patent-pending method opens doors for the open source research and development of biotech, and is designed to allow the industry the same advancements the currently flourishing IT market enjoyed.